Motif Bio Share Discussion Threads

[scottdavid70] 25/5/2021 19:14

7.20pm a guide to broker research - that’s good comedy there to break things up - some of the greatest works of fiction produced week in week out

[melloteam] 25/5/2021 15:19

There is a Mello Healthcare Sector special zoom event this evening with six companies from the sector doing presentations and three investors and fund managers doing short presentations too. Here is the webpage and links to sign up for the event



The show will start from 5.30pm and all attendees will also receive a recording of the show. If you would like a ticket for just £4 use this code SHVIP75 as it gives 75% off

Programme for the evening

5.30 pm Mello Welcome with Edmund Shing

5.35 pm Company presentation by International Biotechnology Trust

6.10 pm Company presentation by Inspiration Healthcare

6.40 pm Charity Pledge by Melwin Mehta – Shield Therapeutics (STX)

6.50 pm Company presentation by Diaceutics

7.20 pm A guide to broker research with Rob Mundy of Research Tree

7.30 pm Company presentation by Angle PLC

8.00 pm Charity Pledge by Tim Grattan – New IPO Arecor

8.10 pm Company presentation by Polarean Imaging

8.40 pm Company presentation by Net Scientific

9.10 pm Healthcare Sector Review from Edmund Shing and Charity Pledge – Circassia (CIR)

[scottdavid70] 25/5/2021 12:03

Even when Motif Bio owned Iclaprim we never got told about the two new patents filed in 2019

Another question for the General Meeting

Why we weren’t told makes me again, given these Directors past history, super suspicious

[scottdavid70] 25/5/2021 12:02

Wry muck looking forward to the General Meeting answering the biggest elephant in the room though

Why did Graham Lumsden say that the CRL states no more clinical trials were indicated for Iclaprim when the outcome was full phase iii?

Is it because they knew then the Motif Bio Director’s in the CRL that there was no way the 3 options Graham Lumsden stated on a Proactive Investors interview weren’t a likely outcome from the FDA decision?

So in effect was Graham Lumsden factually correct to say they didn’t indicate further trials for ABSSSI because as we know the next set of phase iii was for HARP wasn’t?

I think if that scenario is the one which for many of us long term holders seems the more feasible it’s not being economical with the truth it’s running the truth on carbo neutral emissions

I don’t believe a word any of them say and I will never rest till I know what Orange Avenue Technologies LLC is all about

[scottdavid70] 25/5/2021 11:55

Bet365 have stopped taking bets on that scenario Chuffer

Remember Graham Lumsden is the cowardly former CEO who moved the AGM forward in 2019 so he could escape the inevitable grilling by hard working ordinary shareholders. He should have waited to hold the AGM post the FDA decision as the years previous AGM had been later. However, he didn’t want to face in person the very people he had FAILED

He would have had to answer a raft of questions like why he personally hadn’t bought shares or any of the other Directors if Iclaprim was such a surprise it was declined approval? Strange as we know how greedy they all were yet didn’t buy shares in the very asset they were touting as undervalued at 40p a share and shouting broker notes of a £1 a share in interviews

Also he would have had to have answered why he pulled the HARP trials and EMA submission but we found out in a company presentation first not a RNS

Why were liver experts on standby if there were no liver issues? Strange one that

Now they would have to answer why there is no mention who else is on the Board and where is Orange Avenue Technologies LLC incorporated? Doubt they want to face that because there is definitely something very untoward about the section that set up

Why sell it to a man who couldn’t sell it for 18 months - looking forward to the answer to that one at the General Meeting

BIOMARCK shareholders you have been warned

So will they drop a 4.30pm RNS Friday based on past behaviour? I would say EXTREMELY LIKELY

[scottdavid70] 25/5/2021 09:57

Sat with a friend going through us corporation sites in Delaware, Florida etc in the USA

Absolutely nothing

Why the secrecy???????

[scottdavid70] 25/5/2021 09:55

Imagine a bank saying you could access your money that we have had since July last year in April but then don’t allow access until several months later? They would be fined millions

This is in effect what Motif Bio are doing by missing the countless deadlines self-imposed and otherwise

[scottdavid70] 25/5/2021 06:59

Jonathan Gold didn’t even mention MARKETING in the end of January RNS regarding the RTO

They then mentioned MARKETING in the end of March RNS

Then MOTIF BIO said it was “CONFIDENTIAL MARKETING”

Just another brick in the opaqueness of this saga and another angle for my book and articles

Why the incremental increase and escalation of secrecy?

[scottdavid70] 24/5/2021 09:23

Let’s remember when the Chairman says

" what we consider to be a compelling and value creating RTO opportunity for shareholders "

Some are very much judging him on a company that was with over $100 million and 30 - 40p a share before the Directors FAILED to get the asset they were confident of getting approved.

Let’s see EXACTLY what compelling and value creation really is given this Board also said it had ALL BASES COVERED along with many other such promises

[scottdavid70] 24/5/2021 06:26

The ‘confidential’ marketing must have really gone so well that they still can’t announce anything that should have been done by end of March.

One thing any of us who have been invested here for any time over 2 years is that no news is definitely NOT GOOD NEWS WITH THESE DIRECTORS

[scottdavid70] 23/5/2021 08:17

Anyone who thinks that the Director’s giving up their cash incentives to support the transaction is them growing consciences hasn’t been here long enough.

These men after all asked for MORE MONEY IN SALARIES AFTER THEY HAD FAILED TO GET ICLAPRIM APPROVED AND WILED OVER 98% OF INVESTORS VAKUE OUT.

Leopards don’t change their spots so the two scenarios are:

The Orange Avenue Technologies LLC is a secret cash cow for them and they already have a buyer but are using the RTO to deflect attention away and they will recoup their “Good Samaritan” gesture there

Or

The transaction is so bad that had to give up their cash incentives to get the pathetic deal across the line for Motifs long suffering shareholders and run away trying to show what good characters they have by ‘giving up’ their incentives but in reality were forced too

Neither one is appealing to long term hard working ordinary shareholders who believe the words of this Board

[scottdavid70] 22/5/2021 11:56

At the General Meeting why shareholders weren’t invited to participate in the ‘confidential’ fundraise delists being the ones who have borne the entirety of the losses here.

Also have voted for the restructuring and the risks that entailed.

The disrespect and disregard shown to the very people who have made those decisions so these Director’s can try to salvage their reputations is disgraceful

[scottdavid70] 22/5/2021 11:53

The whole something is better than nothing is what these Director’s bank on - don’t accept it at all. Totally the wrong mentality as shareholders- together you have so much more power in these times with authorities and social media able to now make sure people are accountable where in the past they were not.

These Director’s doubles the salaries etc from 2019 - having FAILED - someone needs to have a serious look at that grotesque greed - unacceptable use of shareholders money who have lost virtually all of their investments to date

[tnt99] 22/5/2021 09:08

Got to be next week anticipate a 80-90 per cent loss on this one dilution gonna be big if it happens but hey better than nothing and at least we are still in the gameAnd maybe lawyers will get involved to sue them on a no win no pay platform

[jibba jabber] 22/5/2021 07:08

To add to that, and also treat them with apparent contempt.

[jibba jabber] 22/5/2021 07:07

Where is the regulator in all this mess? Surely someone in authority/who has the authority at the FCA is looking at what's going on here? I find it absolutely bizarre that these people can do what they want at the expense of the people who funded them throughout the journey.

[scottdavid70] 22/5/2021 06:37

Oh and just for the uninitiated on LSE Jonathan Gold will become a non-executive Director of the enlarged group

Not because Iclaprim is involved that’s been carved off into Orange Avenue Technologies LLC and many feel perhaps Lumsden and Gold benefit individually from that along with the man who couldn’t sell it John Palmer

But the enlarged group is your current shares consolidated (much small amount for the LSE crew) and then added to Armageddon amount of shares issued through the ‘confidential’ marketing, that the loyal hard working ordinary investor wasn’t party too despite being the ones who funded the Director’s lavish lifestyles, basically blowing your value into oblivion but granting Jonathan Gold massive free equity no doubt and yours basically worthless

That’s what it means by enlarged group - the Good Samaritan Gold gives up his cash incentive but gains in free equity while you however, lose lose

[scottdavid70] 22/5/2021 06:27

Walbrook PR
Motif Bio
Jonathan Gold
Graham Lumsden
Chris Wardhuagh

Almost double the PR budget in 2020 to 2019 and we have heard less about Motif Bio - Iclaprim and zero promotion of the RTO

So what had the money been spent on?

How can you justify such an increase when the company is just a cash shell with no operations?

[scottdavid70] 21/5/2021 16:01

A RTO can be done in 4 weeks - this one has taken nearly 5 months - e small extra layer for the ‘audit’ has taken over 7 weeks - countless deadlines missed - zero accountability- zero penalties for the people who have missed those self appointed deadlines

Total disdain for the very people whom have allowed these Director’s to flourish financially whilst those who provided the funds to allow them to flourish remain in the dark like mushrooms even after all this time

[scottdavid70] 21/5/2021 06:44

31st May is a Monday - this is not the last weekend you won’t know how much you have lost - possible still everything

Remember these are the people who told you no more clinical trials - all bases covered and that the RTO was due to a Covid opportunity

Don’t believe anything that comes out of their mouths

[scottdavid70] 20/5/2021 15:20

Let’s be clear - the salaries they have purged on from the fundraises and gorged on for the last 2 and a half year whilst asking for even more in salaries unbelievably in 2019 POST FAILURE TO GET ICLAPRIM APPROVED - just to get our money back isn’t a success story for these Director’s.

Their individual roles and stories are well documented and will be told. Any company like Biomarck who hires a Director whom was previously at Motif Bio needs to know their background and what ACTUALLY WAS SAID AND WHAT ACTUALLY HAPPENED